Cellid, Co., Ltd. (299660.KQ)

KRW 3965.0

(12.01%)

Net Debt Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual net debt in 2023 was -1.38 Billion KRW , down -137.73% from previous year.
Cellid, Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 9.58 Billion KRW , up 45.31% from previous quarter.
Cellid, Co., Ltd. reported annual net debt of 3.67 Billion KRW in 2022, down -65.4% from previous year.
Cellid, Co., Ltd. reported annual net debt of 10.61 Billion KRW in 2021, up 414.4% from previous year.
Cellid, Co., Ltd. reported quarterly net debt of 9.58 Billion KRW for 2024 Q2, up 45.31% from previous quarter.
Cellid, Co., Ltd. reported quarterly net debt of 4.1 Billion KRW for 2023 Q2, up 612.53% from previous quarter.

Annual Net Debt Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Net Debt of Cellid, Co., Ltd. (2023 - 2015)

Year	Net Debt	Net Debt Growth
2023	-1.38 Billion KRW	-137.73%
2022	3.67 Billion KRW	-65.4%
2021	10.61 Billion KRW	414.4%
2020	-3.37 Billion KRW	-110.76%
2019	-1.6 Billion KRW	-80.97%
2018	-885.28 Million KRW	64.73%
2017	-2.5 Billion KRW	-57.69%
2016	-1.59 Billion KRW	-280.26%
2015	-418.55 Million KRW	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	6.59 Billion KRW	576.17%
2024 Q2	9.58 Billion KRW	45.31%
2023 Q2	4.1 Billion KRW	612.53%
2023 Q1	576.73 Million KRW	-84.3%
2023 Q4	-1.38 Billion KRW	65.89%
2023 Q3	-4.06 Billion KRW	-198.88%
2023 FY	-1.38 Billion KRW	-137.73%
2022 Q4	3.67 Billion KRW	-60.29%
2022 Q2	9.05 Billion KRW	71.9%
2022 FY	3.67 Billion KRW	-65.4%
2022 Q1	5.26 Billion KRW	-50.39%
2022 Q3	9.25 Billion KRW	2.18%
2021 Q2	8.98 Billion KRW	57.48%
2021 FY	10.61 Billion KRW	414.4%
2021 Q3	9.86 Billion KRW	9.81%
2021 Q4	10.61 Billion KRW	7.61%
2021 Q1	5.7 Billion KRW	266.99%
2020 Q1	-5.49 Billion KRW	-237.72%
2020 Q2	-4.25 Billion KRW	22.46%
2020 FY	-3.37 Billion KRW	-110.76%
2020 Q3	-2.73 Billion KRW	35.73%
2020 Q4	-3.41 Billion KRW	-24.82%
2019 FY	-1.6 Billion KRW	-80.97%
2019 Q3	-720.09 Million KRW	62.44%
2019 Q1	-7.82 Billion KRW	-783.39%
2019 Q4	-1.62 Billion KRW	-125.81%
2019 Q2	-1.91 Billion KRW	75.49%
2018 Q1	4.5 Billion KRW	279.69%
2018 FY	-885.28 Million KRW	64.73%
2018 Q2	-6.55 Billion KRW	-245.35%
2018 Q4	-885.28 Million KRW	0.0%
2017 FY	-2.5 Billion KRW	-57.69%
2017 Q1	3.29 Billion KRW	0.0%
2017 Q4	-2.5 Billion KRW	0.0%
2016 FY	-1.59 Billion KRW	-280.26%
2015 FY	-418.55 Million KRW	0.0%

Peer Net Debt Comparison of Cellid, Co., Ltd.

Name	Net Debt	Net Debt Difference
Sam Chun Dang Pharm. Co., Ltd	13.19 Billion KRW	110.501%
Hyundai Bioscience Co., Ltd.	3.73 Billion KRW	137.11%
ST Pharm Co.,Ltd.	141.98 Billion KRW	100.976%
ABL Bio Inc.	15.87 Billion KRW	108.731%